FMO5 and Obesity: The expression of angiotensinogen is enhanced in the setting of obesity and insulin resistance and exerts its pro-oxidative, pro-inflammatory, and pro-fibrotic functions via NF-κB signaling enhancement and NADPH oxidase activity induction.